TY - JOUR
T1 - Three-Year Observation of Children 3 to 10 Years of Age with Untreated Intermittent Exotropia
AU - The Pediatric Eye Disease Investigator Group
AU - Mohney, Brian G.
AU - Cotter, Susan A.
AU - Chandler, Danielle L.
AU - Holmes, Jonathan M.
AU - Wallace, David K.
AU - Yamada, Tomohiko
AU - Petersen, David B.
AU - Kraker, Raymond T.
AU - Morse, Christie L.
AU - Melia, B. Michele
AU - Wu, Rui
N1 - Funding Information:
Supported by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant nos.: EY011751, EY023198, and EY018810). The funding organization had no role in the design or conduct of this research.
Publisher Copyright:
© 2019 American Academy of Ophthalmology
PY - 2019/9
Y1 - 2019/9
N2 - Purpose: To describe the course of intermittent exotropia (IXT) in children followed up without treatment for 3 years. Design: Observation arm from randomized trial of short-term occlusion versus observation. Participants: One hundred eighty-three children 3 to 10 years of age with previously untreated IXT and 400 seconds of arc (arcsec) or better near stereoacuity. Methods: Participants were to receive no treatment unless deterioration criteria were met at a follow-up visit occurring at 3 months, 6 months, or 6-month intervals thereafter for 3 years. Main Outcome Measures: The primary outcome was deterioration by 3 years, defined as meeting motor criterion (constant exotropia ≥10 prism diopters [Δ] at distance and near) or near stereoacuity criterion (≥2-octave decrease from best previous measure). For the primary analysis, participants also were considered to have deteriorated if treatment was prescribed without meeting either deterioration criterion. Results: The cumulative probability of protocol-specified deterioration by 3 years was 15% (95% confidence interval, 10%–22%), but that was likely an overestimate, partly because of misclassification. Among 25 deteriorations, 2 met motor deterioration, 11 met stereoacuity deterioration, and 12 started treatment without meeting either criteria (7 for social concern, 1 for diplopia, 4 for other reasons). Among the 132 participants who completed the 3-year visit and had not been treated during the study, only 1 (<1%) met motor or stereoacuity deterioration criteria at 3 years. Of the 4 participants completing the 3-year visit who met deterioration criteria previously and had not started treatment, none still met deterioration criteria. Between the baseline and 3-year examination for these 132 patients, improvement occurred in distance and near stereoacuity (mean improvement, 0.14 and 0.14 logarithm of arcsec; P ≤ 0.001 and P ≤ 0.001, respectively), distance exotropia control (mean improvement, 0.6 points; P ≤ 0.001), and distance exodeviation magnitude (mean improvement, 2.2 Δ; P = 0.002). Conclusions: Among children 3 to 10 years of age with IXT for whom surgery was not considered to be the immediately necessary treatment, stereoacuity deterioration or progression to constant exotropia over 3 years was uncommon, and exotropia control, stereoacuity, and magnitude of deviation remained stable or improved slightly.
AB - Purpose: To describe the course of intermittent exotropia (IXT) in children followed up without treatment for 3 years. Design: Observation arm from randomized trial of short-term occlusion versus observation. Participants: One hundred eighty-three children 3 to 10 years of age with previously untreated IXT and 400 seconds of arc (arcsec) or better near stereoacuity. Methods: Participants were to receive no treatment unless deterioration criteria were met at a follow-up visit occurring at 3 months, 6 months, or 6-month intervals thereafter for 3 years. Main Outcome Measures: The primary outcome was deterioration by 3 years, defined as meeting motor criterion (constant exotropia ≥10 prism diopters [Δ] at distance and near) or near stereoacuity criterion (≥2-octave decrease from best previous measure). For the primary analysis, participants also were considered to have deteriorated if treatment was prescribed without meeting either deterioration criterion. Results: The cumulative probability of protocol-specified deterioration by 3 years was 15% (95% confidence interval, 10%–22%), but that was likely an overestimate, partly because of misclassification. Among 25 deteriorations, 2 met motor deterioration, 11 met stereoacuity deterioration, and 12 started treatment without meeting either criteria (7 for social concern, 1 for diplopia, 4 for other reasons). Among the 132 participants who completed the 3-year visit and had not been treated during the study, only 1 (<1%) met motor or stereoacuity deterioration criteria at 3 years. Of the 4 participants completing the 3-year visit who met deterioration criteria previously and had not started treatment, none still met deterioration criteria. Between the baseline and 3-year examination for these 132 patients, improvement occurred in distance and near stereoacuity (mean improvement, 0.14 and 0.14 logarithm of arcsec; P ≤ 0.001 and P ≤ 0.001, respectively), distance exotropia control (mean improvement, 0.6 points; P ≤ 0.001), and distance exodeviation magnitude (mean improvement, 2.2 Δ; P = 0.002). Conclusions: Among children 3 to 10 years of age with IXT for whom surgery was not considered to be the immediately necessary treatment, stereoacuity deterioration or progression to constant exotropia over 3 years was uncommon, and exotropia control, stereoacuity, and magnitude of deviation remained stable or improved slightly.
UR - http://www.scopus.com/inward/record.url?scp=85062044867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062044867&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2019.01.015
DO - 10.1016/j.ophtha.2019.01.015
M3 - Article
C2 - 30690128
AN - SCOPUS:85062044867
SN - 0161-6420
VL - 126
SP - 1249
EP - 1260
JO - Ophthalmology
JF - Ophthalmology
IS - 9
ER -